Drugs / Theramine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01490905 | Sep 2010 → Feb 2011 | chronic pain syndrome | Targeted Medical Pharma | Completed | No outcome recorded |
Also used as a comparator or background therapy in 3 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT01468025 Comparator | Feb → Jul 2009 | — | Targeted Medical Pharma | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT01944059 Comparator | Nov 2013 → Dec 2014 | migraine disorder | Vincent Martin, MD | Terminated | No outcome recorded |
| Phase 4 | NCT01534286 Comparator | Aug 2012 → Dec 2013 | — | Targeted Medical Pharma | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Theramine | “Theramine two capsules twice daily and ibuprofen 400mg once daily for 28 days.” NCT01490905 ↗ |
| Modality | Other / unclassified | “Theramine (A medical food)” NCT01490905 ↗ |